Zobrazeno 1 - 10
of 33
pro vyhledávání: '"L V Nikankina"'
Autor:
O K Vikulova, Z T Zuraeva, O V Michaleva, L V Nikankina, M Sh Shamkhalova, M V Shestakova, I I Dedov
Publikováno v:
Терапевтический архив, Vol 90, Iss 6, Pp 59-64 (2018)
The purpose of our study is to assess the effects of glucagon-like peptide-1 receptor agonists (GLP-1R agonists) on early markers of kidney damage in patients with type 1 diabetes mellitus (DM). Materials and methods. The study included 27 patients w
Externí odkaz:
https://doaj.org/article/8c6287e224d1412092f8e90cca987cc8
Autor:
L L Bolotskaya, E G Bessmertnaya, M V Shestakova, M Sh Shamkhalova, L V Nikankina, A V Ilyin, I S Glek, A V Zolotukhin, I I Dedov
Publikováno v:
Терапевтический архив, Vol 89, Iss 10, Pp 17-21 (2017)
Aim. To assess the time course of changes in the level of glycated hemoglobin (HbA1c) for 20 years after the onset of type 1 diabetes mellitus (T1DM) and to compare its correlation with the development of microvascular complications, such as diabetic
Externí odkaz:
https://doaj.org/article/9b192e576f1b4bc4bb772602ed17461d
Autor:
A M Glazunova, M S Arutyunova, E V Tarasov, L V Nikankina, A V Ilyin, M Sh Shamkhalova, M V Shestakova, Ya G Moysyuk
Publikováno v:
Терапевтический архив, Vol 88, Iss 10, Pp 25-34 (2016)
Aim. To study the markers of renal graft dysfunction in patients with type 1 diabetes mellitus (T1DM) after kidney transplantation (KT) and simultaneous pancreas-kidney transplantation (SPKT). Subjects and methods. The investigation enrolled 20 patie
Externí odkaz:
https://doaj.org/article/73bf5084b53b4648a5cdc7c504231688
Autor:
Марианна Viktorovna Yaroslavtseva, Irina Nikolaevna Ul'yanova, Gagik Radikovich Galstyan, A V Ilin, L V Nikankina, Oleg Valer'evich Remizov, Ivan Ivanovich Dedov
Publikováno v:
Сахарный диабет, Vol 12, Iss 1, Pp 25-28 (2009)
Aim. To study the OPG/RANKL system in patients with diabetes mellitus, mediacalcinosis and obliterating atherosclerosis of lower leg arteries. Materials and methods. The study enrolled 70 patients including 20 with manifest diabetic neuropathy (DN) a
Externí odkaz:
https://doaj.org/article/f8a352a263504463b70f557243c15cad
Autor:
A N Podgrebel'nyy, Olga Mikhailovna Smirnova, Ivan Ivanovich Dedov, A V Il'in, L V Nikankina, M V Kotel'nikov, Yu I Chernyad'eva, Yury Ivanovich Suntsov
Publikováno v:
Сахарный диабет, Vol 8, Iss 1, Pp 26-31 (2005)
Цель. Изучение уровня TGFbl и bFGF у пациентов с высоким коронарным риском (20-40%) по Coronary Risk Chart for Primary Prevention (European and other Societies on Coronary Prevention) с СД т
Externí odkaz:
https://doaj.org/article/166aad84d62242b0b82a8a85aada43fc
Autor:
M. M. Kalandiya, E. A. Kogan, L. V. Nikankina, A. Y. Tokmakova, E. L. Zaitseva, G. R. Galstyan
Publikováno v:
Сахарный диабет, Vol 26, Iss 6, Pp 549-555 (2023)
BACKGROUND: Diabetic neuroosteoarthropathy is a severe and insufficiently studied complication of diabetes mellitus, which is characterized by progressive destruction of bones and joints against the background of neuropathy and leads to the formation
Externí odkaz:
https://doaj.org/article/09f4d6c7256247b5a5dd92e9ce417ccd
Autor:
E. M. Romanenkova, I. M. Zufarova, D. Y. Sorokin, I. A. Eremina, E. A. Sechko, L. V. Nikankina, V. A. Peterkova, O. B. Bezlepkina, D. N. Laptev
Publikováno v:
Сахарный диабет, Vol 26, Iss 3, Pp 204-212 (2023)
BACKGROUND: Type 1 diabetes mellitus (T1D) is an autoimmune disorder that leads to pancreatic β-cells destruction and progressive decrease of insulin secretion. Specific islet autoantibodies (AAbs) are the main diagnostic marker of T1D. Residual β-
Externí odkaz:
https://doaj.org/article/46ebafde09634348ba1e1b7a421f5ed1
Autor:
E. A. Sechko, E. M. Romanenkova, I. A. Eremina, L. I. Zilberman, L. V. Nikankina, Z. T. Zuraeva, O. B. Bezlepkina, V. A. Peterkova, D. N. Laptev
Publikováno v:
Сахарный диабет, Vol 25, Iss 5, Pp 449-457 (2022)
BACKGROUND: T1D is characterized by autoimmune destruction of pancreatic β-cells, which develops due to genetic and environmental risk factors. Shortly after initiating the treatment with insulin, 80% of children with T1D may require smaller doses o
Externí odkaz:
https://doaj.org/article/2ccbc67cff294dadb606633ddbabed81
Autor:
E. L. Zaitseva, M. M. Kalandiya, A. Yu. Tokmakova, N. M. Malysheva, L. V. Nikankina, G. R. Galstyan
Publikováno v:
Сахарный диабет, Vol 25, Iss 5, Pp 485-491 (2022)
BACKGROUND: Diabetic neuroosteoarthropathy (DNOAP, Charcot foot) is a relatively rare complication of diabetes mellitus (DM), which can lead not only to impaired support function of the lower limb in such patients, but also to high amputation. DNOAP
Externí odkaz:
https://doaj.org/article/7cc67d7d91f245ca98b699b3cb85182b
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 7, Pp 445-458 (2020)
Rationale: In Russia, assessment of anti-P450c21 antibodies (AB) in the diagnosis of autoimmune adrenal insufficiency (AAI) has not been commonly used, and the disease screening has not been implemented.Aims: 1) To determine the sensitivity and speci
Externí odkaz:
https://doaj.org/article/f3deee626e0745828e18d131fc8aa531